gvs 111 has been researched along with Cerebral Ischemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shabanov, PD; Zarubina, IV | 1 |
| Barskov, IV; Gudasheva, TA; Mirzoev, TK; Ostrovskaya, RU; Romanova, GA; Victorov, IV | 1 |
| Andreeva, NA; Gudasheva, TA; Isaev, NK; Ostrovskaya, RU; Stel'mashuk, EV; Viktorov, IV | 1 |
3 other study(ies) available for gvs 111 and Cerebral Ischemia
| Article | Year |
|---|---|
Noopept reduces the postischemic functional and metabolic disorders in the brain of rats with different sensitivity to hypoxia.
Topics: Animals; Behavior, Animal; Brain; Brain Ischemia; Dipeptides; Hypoxia; Lipid Peroxidation; Male; Neuroprotective Agents; Rats; Rats, Wistar; Swimming | 2009 |
Antiamnesic effect of acyl-prolyl-containing dipeptide (GVS-111) in compression-induced damage to frontal cortex.
Topics: Animals; Brain Ischemia; Cerebral Cortex; Dipeptides; Male; Nootropic Agents; Rats | 2000 |
Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress.
Topics: 2-Amino-5-phosphonovalerate; Animals; Brain Ischemia; Cells, Cultured; Cerebellum; Dipeptides; Glucose; Glutamic Acid; Neurons; Neuroprotective Agents; Nootropic Agents; Oxidative Stress; Oxygen; Piracetam; Rats; Rats, Wistar | 2000 |